期刊文献+

脓毒症、严重脓毒症及脓毒性休克患儿血清白蛋白水平与预后关系的研究 被引量:5

Relationship between serum albumin level and prognosis in children with sepsis, severe sepsis and septic shock
原文传递
导出
摘要 目的 探讨脓毒症、严重脓毒症及脓毒性休克患儿血清白蛋白水平与预后的相关性.方法 选取南阳市第一人民医院收治的142例患儿作为研究对象,其中脓毒症50例,严重脓毒症48例,脓毒性休克44例,对三组患儿均在纳入研究之后24h检测血清白蛋白,观察并对比各组患儿预后及低白蛋白血症发生情况.结果 脓毒症组30例(60.0%)患儿发生低白蛋白血症,严重脓毒症组和脓毒性休克组分别为41例(85.4%)和44例(100.0%),各组患儿低白蛋白血症发生率比较差异有统计学意义(P<0.05);且各组低白蛋白血症患儿病死率、存活率比较差异有统计学意义(P<0.05),患儿PCIS评分、病死率与血清白蛋白浓度分别呈正相关和负相关(P<0.05).结论 严重脓毒症与脓毒性休克患儿的低白蛋白血症发病率明显高于脓毒症患儿发病率,患儿的血清白蛋白水平与其预后具有密切相关性. Objective To investigate the correlation of serum albumin level with prognosis in children with sepsis,severe sepsis and septic shock.Methods One hundred and forty-two patients were selected as the research objects,there were 50 cases of sepsis,48 cases of severe sepsis,44 cases of septic shock.Serum albumin were detected after inclusion in the study within 24 h.And the incidence of hypoalbuminemia and patient' s prognosis in each group were observed and compared.Results There were 30 cases (60.0%) of hypoalbuminemia in sepsis group,and 41 cases (85.4%) and 44 cases (100%) in severe sepsis and septic shock group.There was significant difference in the incidence of hypoalbuminemia among the three groups(P 〈 0.05).The fatality rate and survival rate among the three groups had significant differences (P 〈 0.05).Children' s PCIS score was positively correlated with the levels of albumin,and the fatality rate was negatively correlated with the levels of albumin (P 〈 0.05).Conclusions The incidence of hypoalbuminemia in children with severe sepsis and septic shock is significantly higher than that in the patients with sepsis.There is close correlation of the level of serum albumin in children with its prognosis.
作者 王书华
出处 《中国实用医刊》 2015年第18期62-63,共2页 Chinese Journal of Practical Medicine
关键词 脓毒症 严重脓毒症 脓毒性休克 血清白蛋白水平 预后 Sepsis Severe sepsis Septic shock Serum albumin level Prognosis
  • 相关文献

参考文献6

二级参考文献22

  • 1樊寻梅.儿科感染性休克(脓毒性休克)诊疗推荐方案[J].中华儿科杂志,2006,44(8):596-598. 被引量:205
  • 2孙钢.蛋白丢失性肠病[J].中国消化内镜,2007,1(6):41-45. 被引量:5
  • 3Martin GS, Mannino DM, Eaton S, et al. The epidemiology of sep- sis in the United States from 1979 through 2000 [J]. N Engl J Med, 2003,348 (16) : 1546-1554.
  • 4Angus DC, Linde-Zwirble WT, Lidicker J, et al. Epidemiology of Severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care [J]. Crit Care Med, 2001,29 (7) : 1303-1310.
  • 5Dombrovskiy VY, Martin AA, Sunderram J, et al. Rapid increase in hdspitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003 [J]. Crit Care Med, 2007,35 (5) :1414-1415.
  • 6Rivers E, Nguyen B, Havstad S, et al. Early goal directed therapy in the treatment of severe sepsis and septic shock [J]. N Engl J Med, 2001,345 (8) : 1368-1377.
  • 7Kortgen A, Niederprum P, Bauer M. Implementation of an evi- dence-based "standard operating procedure" and outcome in septic shock[J]. Crit Care Med, 2006,34(4) :943-949.
  • 8Nguyen HB, Rivers EP, Knoblich BP, et al. Early lactate clear- ance is associated with improved outcome in severe sepsis and septic shock[J]. Crit Care Med, 2004,32(8) :1637-1642.
  • 9Fetter R, Artigas A, Levy MM, et al. Improvement in process ofcare and outcome after a muhicenter severe sepsis educational pro- gram in Spain. JAMA, 2008,299(19) :2294-2303.
  • 10Kerr M. SCCM 2009: Sepsis Management "Bundles" Boost Guide- line implementation, reduce mortality [R]. http://www. Med- scape, com//view article/587759.

共引文献40

同被引文献66

  • 1王新颖,李维勤,李宁,黎介寿.内毒素抑制肝细胞白蛋白表达的分子机制研究[J].中国危重病急救医学,2004,16(10):626-628. 被引量:35
  • 2李凯,岑瑛.蛋白同化激素及其应用[J].现代临床医学,2006,32(4):306-308. 被引量:17
  • 3Kjeldson L,Johnsen AH,Sengelov H,et al. Isolation and primary structure of NGAL,a novel protein associated with human neutro- phil gelatinase [J]. J Biol Chem, 1993,268 (14) : 10425-10432.
  • 4Isha J, Dent C, Tarabishi R, et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after car- diac surgery [J]. Lancet,2005,365 (4) : 1231-1238.
  • 5Wheeler DS, Devarajan P, Ma Q, et al. Serum neutrophil gelati- nase-associated lipocalin (NGAL) as a marker of acute kidney in- jury in critically ill children with septic shock [ J ]. Crit Care Med, 2008, 36 (4): 1297-1303.
  • 6Maisel AS, Mueller C, Fitzgerald R, et al. Prognostic utility of plasma neutrophil gelatinase-associated lipocalin in patients with acute heart failure:The NGAL EvaLuation Along with B-type Na- Triuretic Peptide in acately decompensated heart failure (GAL- LANT) trial [J]. Eur J Heart Fail,2011,13 (8) : 1846-1851.
  • 7Shavita L, Dolgokerb I, Ivgic H, et al. Neutrophil Gelatinase-Asso- ciated Lipocalin as a Predictor of Complications and Mortality in Patients Undergoing Non-Cardiac Major Surgery [ J ]. Kidney Blood Press Res, 2011, 34 ( 2 ) : 116-124.
  • 8Dellinger RP, Levy MM, Carlet JM, et al. Surviving sepsis cam- paign:intemational guidelines for management of severe sepsis and septic shock : 2008 [ J ]. Intensive Care Med, 2008,34 (1) : 17-60.
  • 9Bjorkqvist M, Kallman J, Fjaertoft G, et al. Human neutrophil lipocalin:normal levels and use as a marker for invasive infection in the newborn [ J ]. Acta Paediatr, 2004,93 ( 4 ) : 534-539.
  • 10Flo TH, Smith KD, Sato S, et al. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron[ J]. Nature, 2004, 432 ( 7019 ) : 917-921.

引证文献5

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部